Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.05% versus 0.5% for prevention of myopia progression in Dutch children
NL-OMON55937Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (2 arms), sponsored by Erasmus MC. Started Dec 2022; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NL-OMON55937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55937.